Literature DB >> 15531839

Maroteaux-Lamy syndrome.

Siddharth Lakhotia1, Alok Sharma, G P Shrivastava, S K Jain.   

Abstract

Mucopolysaccharidoses are a type of lysosomal storage disorders characterized by defect in the degradation of Mucopolysaccharides due to deficiency of specific lysosomal enzymes leading to their accumulation in various tissues. MPS -VI (Maroteaux-Lamy Syndrome) is an autosomal recessive syndrome due to deficiency of enzyme Aryl- Sulfatase -B, and is characterized by characteristic facies, normal intelligence, Dysostosis multiplex, organomegaly, joint stiffness, corneal clouding and striking inclusions in peripheral blood leucocytes. We present an 8-year-old male child with MPS-VI syndrome, confirmed by enzyme assay.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15531839     DOI: 10.1007/bf02830840

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  4 in total

1.  [A NEW DYSOSTOSIS WITH URINARY ELIMINATION OF CHONDROITIN SULFATE B].

Authors:  P MAROTEAUX; B LEVEQUE; J MARIE; M LAMY
Journal:  Presse Med       Date:  1963-09-25       Impact factor: 1.228

Review 2.  INBORN LYSOSOMAL DISEASES.

Authors:  H G HERS
Journal:  Gastroenterology       Date:  1965-05       Impact factor: 22.682

3.  Chromosomal localization of ARSB, the gene for human N-acetylgalactosamine-4-sulphatase.

Authors:  T Litjens; E G Baker; K R Beckmann; C P Morris; J J Hopwood; D F Callen
Journal:  Hum Genet       Date:  1989-04       Impact factor: 4.132

4.  Mental retardation in a patient with Maroteaux-Lamy.

Authors:  S Vestermark; T Tønnesen; M S Andersen; F Güttler
Journal:  Clin Genet       Date:  1987-02       Impact factor: 4.438

  4 in total
  3 in total

Review 1.  Behavioural phenotypes of the mucopolysaccharide disorders: a systematic literature review of cognitive, motor, social, linguistic and behavioural presentation in the MPS disorders.

Authors:  E M Cross; D J Hare
Journal:  J Inherit Metab Dis       Date:  2013-02-06       Impact factor: 4.982

2.  Prevalence of obstructive sleep apnea in patients with mucopolysaccharidosis types I, II, and VI in a reference center.

Authors:  Gustavo A Moreira; Sandra O Kyosen; Camilla L Patti; Ana Maria Martins; Sergio Tufik
Journal:  Sleep Breath       Date:  2014-04-05       Impact factor: 2.816

3.  Enzyme replacement therapy interruption in patients with Mucopolysaccharidoses: Recommendations for distinct scenarios in Latin America.

Authors:  MarthaL Solano; Alejandro Fainboim; Juan Politei; Gloria L Porras-Hurtado; Ana Maria Martins; Carolina F Moura Souza; Felipe Mendez Koch; Hernan Amartino; Jose Maria Satizábal; Dafne D G Horovitz; Paula F V Medeiros; Rachel S Honjo; Charles M Lourenço
Journal:  Mol Genet Metab Rep       Date:  2020-02-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.